US 8097606
Antiglucocorticoids for the treatment of catatonia
granted A61KA61K31/00A61K31/05
Quick answer
US patent 8097606 (Antiglucocorticoids for the treatment of catatonia) held by Corcept Therapeutics Incorporated expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/00, A61K31/05, A61K31/56, A61K31/567